GE HealthCare Technologies Non-GAAP EPS of $1.34 beats by $0.14, revenue of $5.51B beats by $160M, raises FY guidance
GE HealthCare Technologies Non-GAAP EPS of $1.34 beats by $0.14, revenue of $5.51B beats by $160M, raises FY guidance(摘要待生成)
GEHC Q3 Earnings Call Highlights Raised Outlook and Margin Risks - Zacks Investment Research
GEHC Q3 Earnings Call Highlights Raised Outlook and Margin Risks - Zacks Investment Research(摘要待生成)
GE HealthCare introduces AI-enabled imaging system for cardiac procedures
GE HealthCare introduces AI-enabled imaging system for cardiac procedures(摘要待生成)
GEHC Q3 Earnings Beat Estimates on Strong Growth, '26 View Raised - Zacks Investment Research
GEHC Q3 Earnings Beat Estimates on Strong Growth, '26 View Raised - Zacks Investment Research(摘要待生成)
GE HealthCare Jumps 8% After Earnings Beat and Guidance Rise - StocksToTrade
GE HealthCare shares climbed 8% after quarterly earnings beat expectations and the company raised its full-year outlook. [[fact-mwhig0il3]] Adjusted earnings per share were $1.34, above analyst forecasts. [[fact-hefiktr2b]] Revenue was $5.5 billion, up 7.2% year over year, with growth across all segments. [[fact-1nsgf8q9q]] Management was reported to have raised its full-year outlook after improved year-to-date performance and stronger business momentum. [[fact-hymfll9s5]]
GE HealthCare Shares Rise Over 4% as Q3 Earnings Beat Forecasts and 2026 Guidance Increases - Yahoo Finance
GE HealthCare Shares Rise Over 4% as Q3 Earnings Beat Forecasts and 2026 Guidance Increases - Yahoo Finance(摘要待生成)
GE HealthCare Technologies 8-K (2.02, 5.02, 9.01): reported results of operations
GE HealthCare reported third-quarter 2026 revenue of $5.5 billion, up 7.2%, diluted EPS of $1.36, and raised full-year guidance, including adjusted EPS to $4.95–$5.05; its Patient Care Solutions leader will depart, with Neal Sandy succeeding November 16.
Vertiv, Evercore, Brinker, GE HealthCare And Other Big Stocks Moving Higher On Wednesday
U.S. stocks mixed; Dow gained ~100 points. Vertiv jumped 13.3% on strong results and raised guidance; Ultralife soared 145.8% on buyout news.
GE HealthCare (GEHC) Q3 2026 Earnings Call Transcript
GE HealthCare (GEHC) Q3 2026 Earnings Call Transcript(摘要待生成)
GE HealthCare raises 2026 guidance after Q3 results
On Oct. 28, GE HealthCare reported Q3 revenue growth of 7.2% (6.2% organic), organic orders growth of 4.0%, and adjusted EPS of $1.34, up 25.1% year over year; it raised full-year 2026 guidance. Peer results provide read-through on healthcare-equipment demand.